Synergistic effect of pyrazoles derivatives and doxorubicin in claudin-low breast cancer subtype.

Background: Breast cancer is a global public health problem. For some subtypes, such as Claudin-low, the prognosis is poorer and the treatment is still a challenge. Pyrazoles are an important class of heterocyclic compounds and are promising anticancer agents based on their chemical properties.